# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY

I Background Information:

A 510(k) Number K203680   
B Applicant Maine Molecular Quality Controls, Inc.   
C Proprietary and Established Names BioFire JI Control Panel M420   
D Regulatory Information

<table><tr><td rowspan=1 colspan=1>ProductCode(s)</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>RegulationSection</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>PMN</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 866.3920 -Assayed Quality ControlMaterial For ClinicalMicrobiology Assays</td><td rowspan=1 colspan=1>MI - Microbiology</td></tr></table>

# II Submission/Device Overview:

A Purpose for Submission:

To obtain a substantial equivalence determination for the BioFire JI Control Panel M420

# B Measurand:

Multi-analyte quality control materials

# C Type of Test:

BioFire JI Control Panel M420 is intended for use as an external positive and negative assayed quality control to monitor the performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of Gram positive and Gram negative bacteria: Anaerococcus prevotii/vaginalis, Clostridium perfringens, Cutibacterium avidum/granulosum, Enterococcus faecalis, Enterococcus faecium, Finegoldia magna, Parvimonas micra, Peptoniphilus, Peptostreptococcus anaerobius, Staphylococcus aureus. Staphylococcus lugdunensis, Streptococcus spp., Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, Bacteroides fragilis, Citrobacter, Enterobacter cloacae complex, Escherichia coli, Haemophilus influenzae, Kingella kingae, Klebsiella aerogenes, Klebsiella pneumoniae group, Morganella morganii, Neisseria gonorrhoeae, Proteus spp., Pseudomonas aeruginosa, Salmonella spp., and Serratia marcescens, as well as antimicrobial resistance genes: CTX-M, IMP, KPC, mecA/C and MREJ (MRSA), NDM, OXA-48-like, vanA/B, VIM, and yeast pathogens: Candida and Candida albicans on the BioFire JI Panel assay on the BioFire systems.

# III Intended Use/Indications for Use:

A Intended Use(s): See Indications for Use below.

# B Indication(s) for Use:

BioFire JI Control Panel M420 is intended for use as an external positive and negative assayed quality control to monitor the performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of gram-positive and gram-negative bacteria: Anaerococcus prevotii/vaginalis, Clostridium perfringens, Cutibacterium avidum/granulosum, Enterococcus faecalis, Enterococcus faecium, Finegoldia magna, Parvimonas micra, Peptoniphilus, Peptostreptococcus anaerobius, Staphylococcus aureus, Staphylococcus lugdunensis, Streptococcus spp., Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, Bacteroides fragilis, Citrobacter, Enterobacter cloacae complex, Escherichia coli, Haemophilus influenzae, Kingella kingae, Klebsiella aerogenes, Klebsiella pneumoniae group, Morganella morganii, Neisseria gonorrhoeae, Proteus spp., Pseudomonas aeruginosa, Salmonella spp. and Serratia marcescens, antimicrobial resistance genes: CTX-M, IMP, KPC, mecA/C and MREJ (MRSA), NDM, OXA-48-like, vanA/B, VIM, and yeast pathogens: Candida and Candida albicans on the BioFire JI Panel assay on the BioFire systems. BioFire JI Control Panel M420 is composed of synthetic DNA specifically designed for and intended to be used solely with the BioFire JI Panel assay. This product is not intended to replace manufacturer controls provided with the device.

C Special Conditions for Use Statement(s): Rx - For Prescription Use Only

# D Special Instrument Requirements:

The Biofire JI Control Panel was evaluated on the FilmArray 2.0 and FilmArray Torch instruments.

# IV Device/System Characteristics:

# A Device Description:

BioFire JI Control Panel M420, PIN M420, is a quality control panel consisting of two controls: BioFire JI Positive Control, PIN M42118, and Jl Negative Control, PIN M42218. The Positive Control contains non-infectious surrogate control material; a solution of synthetic DNA in

buffers, stabilizers and preservatives. The DNA in the Positive Control carries nucleic acid corresponding to the genome segments of all the pathogens and antimicrobial resistance genes detected and identified by the BioFire JI Panel assay (see Table 1 below) on the BioFire systems. The Negative Control contains only buffers, stabilizers and preservatives.

Table 1. Pathogens and antimicrobial resistance genes found in BioFire JI Control Panel M420, detected by the BioFire JI Panel Assay.   

<table><tr><td rowspan=1 colspan=4>Analyte</td></tr><tr><td rowspan=1 colspan=4>Gram Positive Bacteria</td></tr><tr><td rowspan=1 colspan=1>Anaerococcusprevotii/vaginalis</td><td rowspan=1 colspan=1>Enterococcus faecalis</td><td rowspan=1 colspan=1>Peptoniphilus</td><td rowspan=1 colspan=1>Streptococcus mutans</td></tr><tr><td rowspan=1 colspan=1>Clostridium perfringens</td><td rowspan=1 colspan=1>Enterococcus faecium</td><td rowspan=1 colspan=1>Peptostreptococcusanaerobius</td><td rowspan=1 colspan=1>Streptococcus agalactiae</td></tr><tr><td rowspan=1 colspan=1>Cutibacterium avidum</td><td rowspan=1 colspan=1>Finegoldia magna</td><td rowspan=1 colspan=1>Staphylococcus aureus</td><td rowspan=1 colspan=1>Streptococcuspneumoniae</td></tr><tr><td rowspan=1 colspan=1>Cutibacteriumgranulosum</td><td rowspan=1 colspan=1>Parvimonas micra</td><td rowspan=1 colspan=1>Staphylococcuslugdunensis</td><td rowspan=1 colspan=1>Streptococcus pyogenes</td></tr><tr><td rowspan=1 colspan=4>Gram Negative Bacteria</td></tr><tr><td rowspan=1 colspan=1>Bacteroides fragilis</td><td rowspan=1 colspan=1>Haemophilus influenzae</td><td rowspan=1 colspan=1>Morganela morganii</td><td rowspan=1 colspan=1>Salmonella spp.</td></tr><tr><td rowspan=1 colspan=1>Citrobacter</td><td rowspan=1 colspan=1>Kingella kingae</td><td rowspan=1 colspan=1>Neisseria gonorrhoeae</td><td rowspan=1 colspan=1>Serratia marcescens</td></tr><tr><td rowspan=1 colspan=1>Enterobacter cloacaecomplex</td><td rowspan=1 colspan=1>Klebsiella aerogenes</td><td rowspan=1 colspan=1>Proteus spp.</td><td rowspan=2 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Escherichia coli</td><td rowspan=1 colspan=1>Klebsiella pneumoniaegroup</td><td rowspan=1 colspan=1>Pseudomonasaeruginosa</td></tr><tr><td rowspan=1 colspan=4>Yeast</td></tr><tr><td rowspan=1 colspan=2>Candida spp.</td><td rowspan=1 colspan=2>Candida albicans</td></tr><tr><td rowspan=1 colspan=4>Antimicrobial Resistance Genes</td></tr><tr><td rowspan=1 colspan=1>CTX-M</td><td rowspan=1 colspan=1>KPC</td><td rowspan=1 colspan=1>NDM</td><td rowspan=1 colspan=1>vanA/B</td></tr><tr><td rowspan=1 colspan=1>IMP</td><td rowspan=1 colspan=1>mecA/C and MREJ(MRSA)</td><td rowspan=1 colspan=1>OXA-48-like</td><td rowspan=1 colspan=1>VIM</td></tr></table>

# B Principle of Operation:

Not applicable.

V Substantial Equivalence Information:

A Predicate Device Name(s): FilmArray BCID2 Control Panel M416 B Predicate 510(k) Number(s): K200010

C Comparison with Predicate(s):   

<table><tr><td colspan="1" rowspan="1">Device &amp; PredicateDevice(s):</td><td colspan="1" rowspan="1">K203680</td><td colspan="1" rowspan="1">K200010</td></tr><tr><td colspan="1" rowspan="1">Device Trade Name</td><td colspan="1" rowspan="1">BioFire JI Control PanelM420</td><td colspan="1" rowspan="1">FilmArray BCID2 ControlPanel M416</td></tr><tr><td colspan="1" rowspan="1">General DeviceCharacteristicSimilarities</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Intended Use/IndicationsFor Use</td><td colspan="1" rowspan="1">BioFire JI Control PanelM420 is intended for use asan external positive andnegative assayed qualitycontrol to monitor theperformance of in vitrolaboratory nucleic acid testingprocedures for the qualitativedetection of gram-positiveand gram-negative bacteria:Anaerococcusprevotii/vaginalis,Clostridium perfringens,Cutibacteriumavidum/granulosum,Enterococcus faecalis,Enterococcus faecium,Finegoldia magna,Parvimonas micra,Peptoniphilus,Peptostreptococcusanaerobius, Staphylococcusaureus, Staphylococcuslugdunensis, Streptococcusspp., Streptococcusagalactiae, Streptococcuspneumoniae, Streptococcuspyogenes, Bacteroidesfragilis, Citrobacter,Enterobacter cloacaecomplex, Escherichia coli,Haemophilus influenzae,Kingella kingae, Klebsiellaaerogenes, Klebsiellapneumoniae group,Morganella morganii,Neisseria gonorrhoeae,Proteus spp., Pseudomonasaeruginosa, Salmonella spp.</td><td colspan="1" rowspan="1">FilmArray BCID2 ControlPanel M416 is intended for useas an external positive andnegative assayed qualitycontrol to monitor theperformance of in vitrolaboratory nucleic acid testingprocedures for the qualitativedetection of antimicrobialresistance genes: CTX-M,IMP, KPC, mcr-1, mecA/C,mecA/C and MREJ (MRSA),NDM, OXA-48-like, vanA/B,VIM; Gram positive and Gramnegative bacteria:Enterococcus faecalis,Enterococcus faecium, Listeriamonocytogenes,Staphylococcus spp.,Staphylococcus aureus,Staphylococcus epidermidis,Staphylococcus lugdunensis,Streptococcus spp.,Streptococcus agalactiae(Group B), Streptococcuspneumoniae, Streptococcuspyogenes (Group A),Acinetobactercalcoaceticusbaumanniicomplex, Bacteroides fragilis,Enteric bacteria, Enterobactercloacaecomplex, Escherichiacoli, Klebsiella aerogenes,Klebsiella oxytoca, Klebsiellapneumoniaegroup, Proteusspp., Salmonella spp., Serratiamarcescens, Haemophilusinfluenzae, Neisseriameningitidis. Pseudomonas</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">and Serratia marcescens,antimicrobial resistancegenes: CTX-M, IMP, KPC,mecA/C and MREJ (MRSA),NDM, OXA-48-like, vanA/B,VIM, and yeast pathogens:Candida and Candidaalbicans on the BioFire JIPanel assay on the BioFiresystems. BioFire JI ControlPanel M420 is composed ofsynthetic DNA specificallydesigned for and intended tobe used solely with theBioFire JI Panel assay. Thisproduct is not intended toreplace manufacturer controlsprovided with the device.</td><td colspan="1" rowspan="1">aeruginosa andStenotrophomonasmaltophilia; and yeastpathogens:Candida albicans,Candida auris, Candidaglabrata, Candida krusei,Candida parapsilosis, Candidatropicalis, and Cryptococcusneoformans/gattii on theBioFire Blood CultureIdentification 2 (BCID2) Panelassay on FilmArray systems.FilmArray BCID2 ControlPanel M416 is composed ofsynthetic DNA specificallydesigned for and intended to beused solely with the BioFireBCID2 Panel assay. Thisproduct is not intended toreplace manufacturer controlsprovided with the device</td></tr><tr><td colspan="1" rowspan="1">Physical Format</td><td colspan="1" rowspan="1">Ready-to-use liquid</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Directions for Use</td><td colspan="1" rowspan="1">Process like patient sample(pipette from synovial fluid)</td><td colspan="1" rowspan="1">Process like patient sample(pipette from blood culture)</td></tr><tr><td colspan="1" rowspan="1">Composition</td><td colspan="1" rowspan="1">Synthetic DNA</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Assay Steps Monitored</td><td colspan="1" rowspan="1">Amplification, detection,identification</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Number of targetsmonitored in one assay</td><td colspan="1" rowspan="1">Multiple, &gt; 30 targets</td><td colspan="1" rowspan="1">Same, &gt;30 targets</td></tr><tr><td colspan="1" rowspan="1">General DeviceCharacteristicDifferences</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Targets</td><td colspan="1" rowspan="1">CTX-M, IMP, KPC, mecA/Cand MREJ (MRSA), NDM,OXA-48-like, vanA/B, VIM,Anaerococcusprevotii/vaginalis,Clostridium perfringens,Cutibacteriumavidum/granulosum,Enterococcus faecalis,Enterococcus faecium,Finegoldia magna,Parvimonas micra,Peptoniphilus,Peptostreptococcusanaerobius, Staphylococcus</td><td colspan="1" rowspan="1">CTX-M, IMP, KPC,mcr-1, mecA/C, mecA/C andMREJ(MRSA), NDM, OXA-48-like,vanA/B, VIM; Enterococcusfaecalis, Enterococcusfaecium, Listeriamonocytogenes,Staphylococcusspp., Staphylococcus aureus,Staphylococcus epidermidis,Staphylococcus lugdunensis,Streptococcus spp.,Streptococcusagalactiae (Group B),</td></tr></table>

<table><tr><td></td><td>aureus. Staphylococcus Streptococcus pneumoniae, lugdunensis, Streptococcus Streptococcus pyogenes spp., Streptococcus (Group A), agalactiae, Streptococcus Acinetobacter calcoaceticus pneumoniae, Streptococcus baumannii complex, pyogenes, Bacteroides Bacteroides fragilis, Citrobacter, fragilis, Enteric bacteria, Enterobacter cloacae Enterobacter cloacae complex, complex, Escherichia coli, Escherichia coli, Klebsiella Haemophilus influenzae, aerogenes, Klebsiella oxytoca, Kingella kingae, Klebsiella Klebsiella pneumoniae group, aerogenes, Klebsiella Proteus spp., Salmonella spp., pneumoniae group, Serratia marcescens, Morganella morganii, Haemophilus Neisseria gonorrhoeae, influenzae, Neisseria Proteus spp., Pseudomonas meningitidis, Pseudomonas aeruginosa, Salmonella spp., aeruginosa and Serratia marcescens, Stenotrophomonas Candida, and Candida maltophilia; and yeast albicans pathogens: Candida albicans, Candida auris, Candida glabrata, Candida krusei, Candida parapsilosis, Candida tropicalis, and Cryptococcus neoformans/gattii</td></tr></table>

# VI Standards/Guidance Documents Referenced:

None referenced.

VII Performance Characteristics (if/when applicable):

# A Analytical Performance:

1. Precision/Reproducibility:

A multi-site reproducibility study was performed with the BioFire JI Control Panel on FilmArray 2.0 and FilmArray Torch systems. Testing included evaluation of 10 samples of each of three lots of BioFire JI Control Panel M420 on different days at three CLIA-certified clinical sites using three BioFire JI Panel pouch lots, incorporating multiple operators for a total of 181 tests (one Invalid result was repeated).

Out of the 90 positive and 90 negative controls tested with valid pouch controls, the correct analytes were detected (for positive controls) or not detected (for negative controls) resulting in a correct call rate of $100 \%$ (Table 2).

Table 2. BioFire JI Control Panel M420: Summary of Reproducibility Results   

<table><tr><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>TotalTests</td><td rowspan=1 colspan=1>Invalid</td><td rowspan=1 colspan=1>CorrectPositiveControlResult</td><td rowspan=1 colspan=1>IncorrectPositiveControlResult</td><td rowspan=1 colspan=1>% CorrectPositive ControlResult(95% CI)</td><td rowspan=1 colspan=1>CorrectNegativeControlResult</td><td rowspan=1 colspan=1>IncorrectNegativeCControlResult</td><td rowspan=1 colspan=1>% CorrectNegative ControlResult(95% CI)</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>61</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>All</td><td rowspan=1 colspan=1>181</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100(95.9%-100.0%)</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100(95.9%-100.0%)</td></tr></table>

\*Invalid result was not included in percent correct

An internal precision study was performed by testing 20 samples of each of three lots of BioFire JI Control Panel M420 on different days with three BioFire JI Panel pouch lots by three operators for a total of 120 tests. The same pouch lots were used for both internal and external testing. All controls gave correct positive or negative results (Table 3).

Table 3. BioFire JI Control Panel M420: Summary of Internal Precision Results   

<table><tr><td rowspan=1 colspan=1>Control</td><td rowspan=1 colspan=1>Lot #</td><td rowspan=1 colspan=1>No. Tests</td><td rowspan=1 colspan=1>Invalid</td><td rowspan=1 colspan=1>CorrectResults</td><td rowspan=1 colspan=1>IncorrectResults</td><td rowspan=1 colspan=1>PercentCorrect[95% CI]</td></tr><tr><td rowspan=4 colspan=1>BioFire JINegativeControl</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%[94-100%]</td></tr><tr><td rowspan=3 colspan=1>BioFire JIPositiveControl</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%[94-100%]</td></tr></table>

A Cp data analysis was also conducted for the precision study results and no significant difference in the mean Cp values was observed based on testing of different Biofire JI Positive control lots on different days by multiple operators at external and internal sites. The reproducibility and precision studies evaluating the BioFire JI Control Panel M420 are acceptable.

2. Linearity: Not applicable.

3. Analytical Specificity/Interference:

Not applicable.

4. Assay Reportable Range: Not applicable.

5. Traceability, Stability, Expected Values (Controls, Calibrators, or Methods): Open Vial Stability

Not applicable because the BioFire JI Control Panel M420 is packaged for single use.

Real-Time Stability Program

Real-time stability studies are ongoing to support product claims and to monitor potential assay modifications for which the BioFire JI Control Panel M420 is indicated for use. Realtime stability study protocols and acceptance criteria were reviewed and found to be acceptable.

# Shipping Stability

MMQCI ships DNA-based controls, such as BioFire JI Control Panel M420, on frozen gel packs with overnight delivery (U.S.), or 4-7 days (ex-U.S.), ensuring that the control material remains cold upon receipt. The control material is expected to be stored at $2 { - } 8 ^ { \circ } \mathrm { C }$ upon receipt, as indicated in the BioFire JI Control Panel M420 package insert. A shipping study was performed to confirm the shipping process does not negatively impact performance, with and without a shipping delay with consequent arrival of gel packs no longer frozen or cold, and to investigate two extreme temperature excursions: $3 7 ^ { \circ } \mathrm { C }$ and - $2 0 \mathrm { { } ^ { \circ } C }$ , that might occur during shipping. The study evaluated two lots of the BioFire JI Positive Control that was placed with two frozen gel packs. After two days, some vials were returned to the refrigerator at $2 { - } 8 ^ { \circ } \mathrm { C }$ , and subsequently tested using the BioFire JI Panel assay, thus representing usual customer receipt of product. To simulate a shipping delay, the remaining ‘shipped’ vials from the two lots of the BioFire JI Positive Control were removed from the shipping box after two days and stored for up to six days at ambient room temperature. The vials were then returned to the refrigerator and subsequently tested using the BioFire JI Panel assay.

The study demonstrated that the BioFire JI Control Panel M420 is stable for two days on frozen gel packs in MMQCI’s standard shipping box. BioFire JI Positive Control is stable after six days at ambient temperatures of approximately $1 9 { - } 2 1 ^ { \circ } \mathrm { C }$ . The BioFire JI Control Panel M420 should be stored refrigerated $( 2 { - } 8 ^ { \circ } \mathrm { C } )$ as indicated in the package insert.

To investigate control performance after exposure to extreme temperatures, two tubes each of two lots of BioFire JI Positive Control were warmed to room temperature, placed at $- 2 0 ^ { \circ } \mathrm { C }$ and $3 7 ^ { \circ } \mathrm { C }$ and subsequently tested using the BioFire JI Panel assay. The results from this study demonstrate that an overnight exposure to $- 2 0 ^ { \circ } \mathrm { C }$ and $3 7 ^ { \circ } \mathrm { C }$ does not impact control performance.

6. Detection Limit: Not applicable.

7. Assay Cut-Off: Not applicable.

# B Comparison Studies:

1. Method Comparison with Predicate Device: Not applicable.

2. Matrix Effects:

The matrix of the BioFire JI Control Panel M420 is synthetic. To investigate the potential effects of the synthetic matrix on the BioFire JI Panel assay, equal volumes of the same concentration of gDNA Streptococcus pneumoniae, strain TCH8431 (BEI Resources, P/N HM-145D) were spiked into $2 7 0 \mu \mathrm { L }$ of BioFire JI Control Panel M420 matrix and $2 7 0 \mu \mathrm { L }$ of synovial fluid (Human Synovial Fluid; Innovative Research), then tested on the BioFire JI Panel assay in triplicate. The acceptance criteria were correct results for all spiked synovial fluid and spiked synthetic matrix samples.

The expected results were obtained for all spiked human synovial fluid and spiked BioFire JI Control Panel M420 synthetic matrix (Detected for Streptococcus spp. and S. pneumoniae, Not Detected for all other assays).

The results indicated that the BioFire JI Control Panel M420 matrix has no effect on the assay.

# C Clinical Studies:

1. Clinical Sensitivity: Not applicable.

2. Clinical Specificity: Not applicable.

3. Other Clinical Supportive Data (When 1. and 2. Are Not Applicable): Not applicable.

# D Clinical Cut-Off:

Not Applicable

# E Expected Values/Reference Range:

BioFire JI Control Panel M420 is a qualitative control and the expected results are listed in the table below.

Table 5. BioFire JI Control Panel M420 Positive and Negative Result Summary   

<table><tr><td></td><td></td><td rowspan=1 colspan=1>EY</td></tr><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>Positive Control</td><td rowspan=1 colspan=1>Negative Control</td></tr><tr><td rowspan=1 colspan=1>Anaerococcus prevotii/vaginalis</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Clostridium perfringens</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Cutibacterium avidum</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Cutibacterium granulosum</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Enterococcus faecalis</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Enterococcus faecium</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Finegoldia magna</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Parvimonas micra</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Peptoniphilus</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Peptostreptococcus anaerobius</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Staphylococcus aureus</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Staphylococcus lugdunensis</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Streptococcus mutans</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Streptococcus agalactiae</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Streptococcus pneumoniae</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Streptococcus pyogenes</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Bacteroides fragilis</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Citrobacter</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Crobacter cloacae complex</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Escherichia coli</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Haemophilus influenzae</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Kingella kingae</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Klebsiella aerogenes</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Klebsiella pneumoniae group</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Morganela morganii</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Neisseria gonorrhoeae</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Proteus spp.</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Pseudomonas aeruginosa</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Salmonella spp.</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Serratia marcescens</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Candida spp.</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=1>Candida albicans</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>Not Detected</td></tr><tr><td rowspan=1 colspan=3>AMR Genes</td></tr><tr><td rowspan=1 colspan=1>CTX-M</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>IMP</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>KPC</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>mecA/C and MREJ (MRSA)</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>NDM</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>OXA-48-like</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>vanA/B</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>VIM</td><td rowspan=1 colspan=1>Detected</td><td rowspan=1 colspan=1>N/A</td></tr></table>

The labeling supports the finding of substantial equivalence for this device.

# IX Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.